Cargando…
Breaking News in Spinal Cord Injury Research: FDA Approved Phase I Clinical Trial of Human, Autologous Schwann Cell Transplantation in Patients with Spinal Cord Injuries
Autor principal: | Xu, Xiao-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302447/ https://www.ncbi.nlm.nih.gov/pubmed/25624788 http://dx.doi.org/10.3969/j.issn.1673-5374.2012.22.001 |
Ejemplares similares
-
Clinical translation of autologous Schwann cell transplantation for the treatment of spinal cord injury
por: Guest, James, et al.
Publicado: (2013) -
Tamoxifen: an FDA approved drug with neuroprotective effects for spinal cord injury recovery
por: Colón, Jennifer M., et al.
Publicado: (2016) -
Edaravone combined with Schwann cell transplantation may repair spinal cord injury in rats
por: Zhang, Shu-quan, et al.
Publicado: (2015) -
Human Schwann Cell Transplantation for Spinal Cord Injury: Prospects and Challenges in Translational Medicine
por: Monje, Paula V., et al.
Publicado: (2021) -
Repair of the Injured Spinal Cord by Schwann Cell Transplantation
por: Fu, Haitao, et al.
Publicado: (2022)